Clinical Trial Imaging Market to Reach USD 2318.9 Million by 2031 Driven by Rising Demand for Precision Diagnostics and Decentralized Clinical Trials
The growing adoption of imaging biomarkers, increasing oncology trials, and technological advancements in diagnostic imaging are among the primary factors accelerating market expansion globally.






